Universität Wien
Warning! The directory is not yet complete and will be amended until the beginning of the term.

270032 VO Medical Radiochemistry II (2020S)

Tracer Development - from Bench to Bed

3.00 ECTS (2.00 SWS), SPL 27 - Chemie

Termine: 11 x 90 min Einheiten, Nuklearmedizin 3L, Bibliothek (AKH Hauptgebäude, Ebene 3, Raum jeweils um 16:30 bis 18 Uhr:
Do.05.03; Di.17.03; Do.19.03; Di.24.03; Do.26.03; Di. 31.03; Do. 02.04; Di. 21.04; Do. 23.04; Di. 28.04 & Do. 30.04
Vorlesungsfrei: (12.03; 06.04 bis 19.04)
Moodle

Registration/Deregistration

Note: The time of your registration within the registration period has no effect on the allocation of places (no first come, first served).
Register/Deregister for this course

Details

Language: German

Examination dates

Lecturers

Classes

Termine: 11 x 90 min Einheiten, Nuklearmedizin 3L, Bibliothek (AKH Hauptgebäude, Ebene 3, Raum jeweils um 16:30 bis 18 Uhr:
Do.05.03; Di.17.03; Do.19.03; Di.24.03; Do.26.03; Di. 31.03; Do. 02.04; Di. 21.04; Do. 23.04; Di. 28.04 & Do. 30.04
Vorlesungsfrei: (12.03; 06.04 bis 19.04)

Information

Aims, contents and method of the course

-Basics in radiopharmaceutical sciences, preclinical evaluation and nuclear medicine
-Pharmacokinetics and Modelling
-Special Challenges in neuro-radiopharmaceutical development (blood brain barrier)
- Methods of radiopharmaceutical drug development and process
-Radiopharmaceuticals for diagnostic, therapeutic use and developments in neuroimaging
-Preclinical studies (in vitro, animal studies) and clinical studies

Assessment and permitted materials

Multiple Choice Test/Oniline Oral Exam

Do, 7.5.20 16:30
Do, 14.5.20 16:30
Do, 25.6.20 16:30

Minimum requirements and assessment criteria

-To learn about the most important pharmacological criteria in radiopharmaceutical drug development
-To know the most important radiopharmaceuticals for nuclear medicine
-To hear about important methods in drug development
-To understand essentials in (radio)pharmacological behavior
-To understand the theranostic concept
-To understand preclinical and clinical study designs (development process)

Examination topics

See above, minimum requirements and assessment criteria

Reading list

1. "Handbook of Radiopharmaceuticals" von Michael Welch und Carol S. Redvanly
2. "Radiopharmaceuticals: in Nuclear Pharmacy and Nuclear Medicine" von Richard J., Ph.D. Kowalsky, Steven W., Ph.D. Falen
3. . ETH ZÜRICH - RADIOPHARMAZEUTISCHE CHEMIE http://www.pharma.ethz.ch/institute_groups/radiopharmaceutical_science/lectures/index
4. Universität Würzburg - KURSUS DER NUKLEARMEDIZIN http://www.uni-wuerzbrug.de/nuklearmedizin/kursus/Kursus.htm
5. 5. The role of radiopharmaceuticals in drug discovery and development. Kairemo K. Curr Pharm Des. 2009;15(9):926-7
6. Molecular Imaging with PET. Ametamey S, Honer M, Schubiger PA, Chem. Rev. 2008, 108, 1501–1516
7. Animal Models for Human Cancer, Edited by Marianne I. Martic-Kehl and P. August Schubiger, Dicovery and Development of Novel Therapeutics, Volume 69

Association in the course directory

AC-4

Last modified: We 19.08.2020 07:49